Search results
Results from the WOW.Com Content Network
Vistaril (hydroxyzine) – an antihistamine for the treatment of itches and irritations, an antiemetic, as a weak analgesic, an opioid potentiator, and as an anxiolytic; Vyvanse (lisdexamfetamine) – a pro-drug stimulant used to treat attention deficit hyperactivity disorder and binge eating disorder; Vyvanse is converted into Dexedrine in vivo
An antiemetic is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, and chemotherapy directed against cancer. They may be used for severe cases of gastroenteritis, especially if the patient is dehydrated. [1] [2]
Aprepitant is classified as an NK 1 antagonist because it blocks signals given off by NK 1 receptors.This, therefore, decreases the likelihood of vomiting in patients. NK 1 is a G protein-coupled receptor located in the central and peripheral nervous system.
Maropitant is safer than other antiemetics used in veterinary medicine, in part because of its high specificity for its target and thus not binding to other receptors in the central nervous system. [6] Side effects in dogs and cats include hypersalivation, diarrhea, loss of appetite, and vomiting.
Chlorpromazine may be used as an antiemetic in dogs and cats, or, less often, as a sedative before anesthesia. [73] In horses, it often causes ataxia and lethargy and is therefore seldom used. [72] [73] It is commonly used to decrease nausea in animals that are too young for other common antiemetics.
Levomepromazine, also known as methotrimeprazine, is a phenothiazine neuroleptic drug.Brand names include Nozinan, Levoprome, Detenler, Hirnamin, Levotomin and Neurocil. It is a low-potency antipsychotic (approximately half as potent as chlorpromazine) with strong analgesic, hypnotic and antiemetic properties that are primarily used in palliative care.
Fosaprepitant, sold under the brand names Emend (US) and Ivemend (EU) among others, is an antiemetic medication, [6] administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved for medical use in the United States, [7] and in the European Union in January 2008. [5]
This page was last edited on 30 September 2017, at 04:27 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.